共 50 条
- [47] Risk factors for the development of tinea pedis and onychomycosis: Real-world evidence from a single-podiatry center, large-scale database in Japan [J]. JOURNAL OF DERMATOLOGY, 2024, 51 (01): : 30 - 39
- [48] The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab-Cilgavimab (Evusheld): Real-World Experience at a Large Academic Center [J]. AMERICAN JOURNAL OF MEDICINE, 2023, 136 (01): : 96 - 99